Clarifying Authority over Nicotine Act of 2021

Hozzl · 2022-12-30T03:04:01Z

Explore the details of House Bill 6286 Clarifying Authority over Nicotine Act of 2021 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

12/30/2022, 3:04 AM

Summary of Bill HR 6286

Bill 117 hr 6286, also known as the Clarifying Authority over Nicotine Act of 2021, aims to address the regulation of nicotine products in the United States. The bill seeks to clarify the authority of the Food and Drug Administration (FDA) over the regulation of nicotine-containing products, including e-cigarettes and other electronic nicotine delivery systems.

The bill outlines specific provisions related to the regulation of nicotine products, including requirements for manufacturers to submit product applications to the FDA for approval. It also addresses the labeling and advertising of nicotine products, as well as restrictions on the sale and distribution of these products to minors.

Additionally, the bill includes provisions related to the enforcement of regulations, including penalties for violations of the law. It also calls for increased research and data collection on the health effects of nicotine products, as well as efforts to educate the public about the risks associated with their use. Overall, the Clarifying Authority over Nicotine Act of 2021 aims to strengthen the FDA's authority to regulate nicotine products and protect public health. It addresses key issues related to the marketing, sale, and use of these products, with the goal of reducing their harmful impact on individuals, particularly young people.

Congressional Summary of HR 6286

Clarifying Authority over Nicotine Act of 2021

This bill expands the statutory authority of the Food and Drug Administration (FDA) to regulate tobacco products by amending the definition of such products.

Currently, the statute defines tobacco products as products intended for human consumption that are made or derived from tobacco. The bill amends the definition to also include products that contain nicotine from any source, excluding foods that only contain trace amounts of naturally occurring nicotine.

Beginning 30 days after this bill's enactment, existing laws, regulations, and related FDA guidance pertaining to tobacco products shall apply to tobacco products as defined under this bill.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 6286

Bill HR 6286 is currently in the status of Bill Introduced since December 14, 2021. Bill HR 6286 was introduced during Congress 117 and was introduced to the House on December 14, 2021. Bill HR 6286's most recent activity was Referred to the Subcommittee on Health. as of December 15, 2021

Bipartisan Support of Bill HR 6286

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 6286

Primary Policy Focus

Health

Alternate Title(s) of Bill HR 6286

Clarifying Authority over Nicotine Act of 2021

To amend the Federal Food, Drug, and Cosmetic Act to vest regulatory authority with respect to tobacco products containing nicotine not made or derived from tobacco, and for other purposes.